FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Unlike rival CDK 4/6 inhibitor abemaciclib, patients don’t need to be lymph-node positive to receive ribociclib after surgery.
Medscape Medical News